Cleared Special

K173094 - OrthoVision

K173094 is the FDA 510(k) clearance for OrthoVision by Ewoosoft Co., Ltd.. It is a Class 2 Radiology device (product code LLZ) cleared through the Special 510(k) pathway after a 27-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2017
Decision
27d
Days
Class 2
Risk

K173094 is an FDA 510(k) clearance for the OrthoVision. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ewoosoft Co., Ltd. (Hwaseong-Si, KR). The FDA issued a Cleared decision on October 26, 2017 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Low regulatory complexity profile. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ewoosoft Co., Ltd. devices

Submission Details

510(k) Number K173094 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date October 26, 2017
Days to Decision 27 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 107d · This submission: 27d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

LK Consulting Group USA, Inc.
Priscilla Chung

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K173094.
ViewPoint 6
K173456 · Ge Medical Systems Ultrasound and Primary · Jan 2018
Advanced Diffusion Analysis (ADA) application
K173467 · Philips Medical Systems Nederland B.V. · Dec 2017
syngo®.via protoNeo (Version VA20)
K173378 · Siemens Healthcare GmbH · Nov 2017
Quantra
K163623 · Hologic, Inc. · Oct 2017
Vitrea Advanced Visualization, Version 7.6
K172855 · Vital Images, Inc. · Oct 2017
ASPIRE Bellus II
K171463 · Fujifilm Medical Systems U.S.A, Inc. · Sep 2017